Abe M - Search Results

1

[Advances in biology and pathogenesis of multiple myeloma].

Kosaka M, Abe M, Takishita M, Ozaki S, Goto T. Kosaka M, et al. Among authors: abe m. Nihon Rinsho. 1995 Mar;53(3):627-35. Nihon Rinsho. 1995. PMID: 7699896 Review. Japanese.

2

Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24.

Ozaki S, Kosaka M, Wakatsuki S, Abe M, Koishihara Y, Matsumoto T. Ozaki S, et al. Among authors: abe m. Blood. 1997 Oct 15;90(8):3179-86. Blood. 1997. PMID: 9376601 Free article.

3

A novel membrane antigen selectively expressed on terminally differentiated human B cells.

Goto T, Kennel SJ, Abe M, Takishita M, Kosaka M, Solomon A, Saito S. Goto T, et al. Among authors: abe m. Blood. 1994 Sep 15;84(6):1922-30. Blood. 1994. PMID: 8080996 Free article.

4

A new immunization protocol for the production of monoclonal antibodies specific for VL subgroups of human immunoglobulins.

Goto T, Abe M, Kosaka M. Goto T, et al. Among authors: abe m. Tokushima J Exp Med. 1990 Dec;37(3-4):89-96. Tokushima J Exp Med. 1990. PMID: 2128783

5

Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE).

Liu H, Ozaki K, Matsuzaki Y, Abe M, Kosaka M, Saito S. Liu H, et al. Among authors: abe m. Clin Exp Immunol. 1995 Jun;100(3):480-5. doi: 10.1111/j.1365-2249.1995.tb03726.x. Clin Exp Immunol. 1995. PMID: 7539726 Free PMC article.

6

Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors.

Ikegame A, Ozaki S, Tsuji D, Harada T, Fujii S, Nakamura S, Miki H, Nakano A, Kagawa K, Takeuchi K, Abe M, Watanabe K, Hiasa M, Kimura N, Kikuchi Y, Sakamoto A, Habu K, Endo M, Itoh K, Yamada-Okabe H, Matsumoto T. Ikegame A, et al. Among authors: abe m. Leukemia. 2012 Sep;26(9):2124-34. doi: 10.1038/leu.2012.78. Epub 2012 Mar 20. Leukemia. 2012. PMID: 22430632

7

Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.

Ozaki S, Abe M, Wolfenbarger D, Weiss DT, Solomon A. Ozaki S, et al. Among authors: abe m. Clin Immunol Immunopathol. 1994 May;71(2):183-9. doi: 10.1006/clin.1994.1070. Clin Immunol Immunopathol. 1994. PMID: 8181187

8

The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.

Asano J, Nakano A, Oda A, Amou H, Hiasa M, Takeuchi K, Miki H, Nakamura S, Harada T, Fujii S, Kagawa K, Endo I, Yata K, Sakai A, Ozaki S, Matsumoto T, Abe M. Asano J, et al. Among authors: abe m. Leukemia. 2011 Jul;25(7):1182-8. doi: 10.1038/leu.2011.60. Epub 2011 Apr 8. Leukemia. 2011. PMID: 21475253

9

Interleukin-1 beta enhances and interferon-gamma suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts.

Abe M, Shintani Y, Eto Y, Harada K, Fujinaka Y, Kosaka M, Matsumoto T. Abe M, et al. Clin Exp Immunol. 2001 Oct;126(1):64-8. doi: 10.1046/j.1365-2249.2001.01644.x. Clin Exp Immunol. 2001. PMID: 11678900 Free PMC article.

10

Effects of LHRH, FSH and activin A on follistatin secretion from cultured rat anterior pituitary cells.

Liu ZH, Shintani Y, Sakamoto Y, Harada K, Zhang CY, Fujinaka Y, Abe M, Goto T, Saito S. Liu ZH, et al. Among authors: abe m. Endocr J. 1996 Jun;43(3):321-7. doi: 10.1507/endocrj.43.321. Endocr J. 1996. PMID: 8886627 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,255 results

Search Page

Filters